TrialCancer communications (London, England)2023

μ-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial.

Xiaoqiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.